Eratrectinib
Eratrectinib (Example 1) is a Trk inhibitor. Eratrectinib can be studied in research for tropomyosin receptor kinase-related diseases and cancers[1].
Product Specifications
CAS Number
[2396516-98-4]
UNSPSC
12352005
Target
Trk Receptor
Related Pathways
Neuronal Signaling; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
FC(C=C1[C@]2([H])N(CCC2)C3=NC4=C5C=NN4C=C3)=CN=C1CCN(C6CC6)NC5=O
Molecular Formula
C21H22FN7O
Molecular Weight
407.44
References & Citations
[1]Yong Wu, et al., Pyrazolo[1,5-a]pyrimidine derivatives as tropomyosin receptor kinase inhibitors and their preparation, pharmaceutical compositions and use in the treatment of diseases. WO2019233461A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
